Literature DB >> 18697437

[Cytokine storm in avian influenza].

Dürdal Us1.   

Abstract

The most dramatic example of defining the pathogenicity of influenza virus A/H5N1 strains is the higher fatality rate of avian influenza epidemic (>50%) occured in Southeast Asia in 1997 comparing to the pandemic caused by influenza virus A/H1N1 in 1918 (5-10%) which was recorded as the most destructive pandemic in the world. When considering the fatal/total case numbers (208/340) reported by World Health Organization in respect of December 14th, 2007, the mortality rate has now reached to 61 percent. Recent studies have shown that the high fatality rate of avian influenza virus infections is a consequence of an overactive inflammatory response and the severity of infection is closely related with virus-induced cytokine dysregulation. The most important feature of A/H5N1 immunopathogenesis is the appearence of hypercytokinemia ("cytokine storm") which is characterized by the extreme (exaggerated) production and secretion of large numbers and excessive levels of pro-inflammatory cytokines. This phenomenon is blamed on the emergence of lethal clinical symptoms such as extensive pulmonary oedema, acute bronchopneumoniae, alveolar haemorrhage, reactive haemophagocytosis, and acute respiratory distress syndrome, associated with necrosis and tissue destruction. Numerous in vitro, in vivo and clinical studies have pointed out that A/H5N1 viruses are very strong inducers of various cytokines and chemokines [Tumor Necrosis Factor (TNF)-alpha, Interferon (IFN)-gamma, IFN-alpha/beta, Interleukin (IL)-6, IL-1, MIP-1 (Macrophage Inflammatory Protein), MIG (Monokine Induced by IFN-gamma), IP-10 (Interferon-gamma-Inducible Protein), MCP-1 (Monocyte Chemoattractant Protein), RANTES (Regulated on Activation Normal T-cell Expressed and Secreted), IL-8], in both humans and animals. The privileged cells of cytokine storm are macrophages and CD8+ T-lymphocytes, while the primary contributor cytokines are TNF-alpha, IL-6 and IFN-gamma. It has been detected that, mutations of some viral genes (NS1, PB2, HA and NA) are responsible for the cytokine storm, by increasing the viral replication rate, expending the tissue tropism, facilitating the systemic invasion and emerging of resistance against the host antiviral response. It has been shown that Glu92 and Ala149 mutations, and carboxyl-terminal ESEV/EPEV motif of NS1 protein have been implicated as determinants of virulence for A/H5N1 strains. In addition, Lys627 mutation in PB2 protein, polybasic aminoacid mutations in the cleavage region of hemagglutinin (HA) polyprotein, and glycosylation and sialylation mutations in HA and neuraminidase (NA) proteins were found to enhance the immune-mediated patology of highly virulent A/H5N1 strains. In this review article, the immunopathogenesis of influenza infection and the mechanisms of cytokine storm caused by influenza A/H5N1 viruses have been discussed under the light of recent literature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18697437

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  30 in total

Review 1.  Targeting the "cytokine storm" for therapeutic benefit.

Authors:  Riccardo V D'Elia; Kate Harrison; Petra C Oyston; Roman A Lukaszewski; Graeme C Clark
Journal:  Clin Vaccine Immunol       Date:  2013-01-02

Review 2.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

Review 3.  Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

Authors:  P Zarogoulidis; N Papanas; I Kioumis; E Chatzaki; E Maltezos; K Zarogoulidis
Journal:  Eur J Clin Pharmacol       Date:  2011-11-22       Impact factor: 2.953

4.  Metabolic pathways of lung inflammation revealed by high-resolution metabolomics (HRM) of H1N1 influenza virus infection in mice.

Authors:  Joshua D Chandler; Xin Hu; Eun-Ju Ko; Soojin Park; Young-Tae Lee; Michael Orr; Jolyn Fernandes; Karan Uppal; Sang-Moo Kang; Dean P Jones; Young-Mi Go
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-08-24       Impact factor: 3.619

5.  Lipopolysaccharide-induced miR-1224 negatively regulates tumour necrosis factor-α gene expression by modulating Sp1.

Authors:  Yuna Niu; Delin Mo; Limei Qin; Chong Wang; Anning Li; Xiao Zhao; Xiaoying Wang; Shuqi Xiao; Qiwei Wang; Ying Xie; Zuyong He; Peiqing Cong; Yaosheng Chen
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

6.  Protein intrinsic disorder and influenza virulence: the 1918 H1N1 and H5N1 viruses.

Authors:  Gerard Kian-Meng Goh; A Keith Dunker; Vladimir N Uversky
Journal:  Virol J       Date:  2009-06-03       Impact factor: 4.099

7.  A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitor.

Authors:  Chuanfu Zhang; Yuanyong Xu; Leili Jia; Yutao Yang; Yong Wang; Yansong Sun; Liuyu Huang; Fei Qiao; Stephen Tomlinson; Xuelin Liu; Yusen Zhou; Hongbin Song
Journal:  Virol J       Date:  2010-02-09       Impact factor: 4.099

8.  Host gene expression profiling in influenza A virus-infected lung epithelial (A549) cells: a comparative analysis between highly pathogenic and modified H5N1 viruses.

Authors:  Alok K Chakrabarti; Veena C Vipat; Sanjay Mukherjee; Rashmi Singh; Shailesh D Pawar; Akhilesh C Mishra
Journal:  Virol J       Date:  2010-09-09       Impact factor: 4.099

Review 9.  Can mesenchymal stem cells be used to treat COVID-19-induced pneumonia? (Review).

Authors:  İdil Çetin; Mehmet Topçul
Journal:  Biomed Rep       Date:  2020-10-16

10.  Evodia rutaecarpa and Three Major Alkaloids Abrogate Influenza A Virus (H1N1)-Induced Chemokines Production and Cell Migration.

Authors:  Wen-Fei Chiou; Han-Chieh Ko; Bai-Luh Wei
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.